The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
118751763 11875176 3 F 20160705 20151229 20160716 EXP US-AUROBINDO-AUR-APL-2015-11649 AUROBINDO 23.00 YR F Y 0.00000 20160716 OT US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
118751763 11875176 1 PS CIPROFLOXACIN. CIPROFLOXACIN 1 Unknown 500 MG, TWO TIMES A DAY N U 77859 500 MG BID
118751763 11875176 2 SS Moxifloxacin 400mg MOXIFLOXACIN 1 Unknown 400 MG, DAILY N U 0 400 MG
118751763 11875176 3 SS Moxifloxacin 400mg MOXIFLOXACIN 1 N U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
118751763 11875176 1 Diarrhoea infectious
118751763 11875176 2 Oropharyngeal pain
118751763 11875176 3 Pyrexia

Outcome of event

Event ID CASEID OUTC COD
118751763 11875176 DS
118751763 11875176 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
118751763 11875176 Abdominal pain
118751763 11875176 Alopecia
118751763 11875176 Amnesia
118751763 11875176 Arthralgia
118751763 11875176 Asthenia
118751763 11875176 Autonomic nervous system imbalance
118751763 11875176 Cognitive disorder
118751763 11875176 Decreased appetite
118751763 11875176 Diarrhoea
118751763 11875176 Disturbance in attention
118751763 11875176 Dizziness
118751763 11875176 Dry eye
118751763 11875176 Dry mouth
118751763 11875176 Dyspnoea
118751763 11875176 Fatigue
118751763 11875176 Gastrointestinal pain
118751763 11875176 Gastrooesophageal reflux disease
118751763 11875176 Hypoaesthesia
118751763 11875176 Hypotension
118751763 11875176 Impaired gastric emptying
118751763 11875176 Inflammation
118751763 11875176 Insomnia
118751763 11875176 Intestinal metaplasia
118751763 11875176 Irritable bowel syndrome
118751763 11875176 Micturition urgency
118751763 11875176 Migraine
118751763 11875176 Mood swings
118751763 11875176 Muscle contractions involuntary
118751763 11875176 Myalgia
118751763 11875176 Mydriasis
118751763 11875176 Nausea
118751763 11875176 Orthostatic intolerance
118751763 11875176 Paraesthesia
118751763 11875176 Polyneuropathy
118751763 11875176 Postural orthostatic tachycardia syndrome
118751763 11875176 Seizure
118751763 11875176 Sinusitis
118751763 11875176 Skin burning sensation
118751763 11875176 Tachycardia
118751763 11875176 Tendonitis
118751763 11875176 Toxicity to various agents
118751763 11875176 Ulcerative keratitis
118751763 11875176 Upper respiratory tract infection
118751763 11875176 Vomiting
118751763 11875176 Weight decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found